SKIN LESIONS. On behalf of Airedale, Wharfedale and Craven CCG, Bradford City CCG and Bradford Districts CCG. Bradford and Airedale CCGs.

Similar documents
SPECIALISED SERVICES POLICY: CP 42 TREATMENT OF BENIGN SKIN CONDITIONS

Benign Skin Lesions and Cosmetic Treatments Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives

Thames Valley Priorities Committee Commissioning Policy Statement

BENIGN SKIN LESIONS INDIVIDUAL FUNDING REQUEST POLICY

Patients who smoke should be encouraged to stop smoking at least 8 weeks before surgery to reduce the risk of surgery and the risk of complications.

V Placename CCG. Policies for the Commissioning of Healthcare. Policy for the Commissioning of Cosmetic Procedures

Revisions to Richmond CCG policies for *Procedures of Limited Clinical Effectiveness

Thames Valley Priorities Committee Commissioning Policy Statement

Commissioning Policy: Treatments Designed to Improve Aesthetic Appearance

Chorley and South Ribble Clinical Commissioning Group and Greater Preston Clinical Commissioning Group (CCG)

Low Priority Treatment Policies

Commissioning Policy Individual Funding Request

The Adult Exceptional Aesthetic Referral Protocol (AEARP) September 2011

Medicare Benefits Schedule: changes to Dermatology items from 1 Nov 2018

Prior Authorization. Additional Information:

London Choosing Wisely. Draft Policy Template: Procedures and Interventions for Benign Skin Lesions. Version Date Notes

Policy for Eyelid Surgery (Upper and Lower)

Minor surgery. Introduction

Page 1 of 17. Version: 5 - Updated: 1 st September MBCCG Policy Ref No. 2 (Pan Lancs) Policy Name. 3 (Pan Lancs)

Monash Health Referral Guidelines

COSMETIC PROCEDURES ANNUAL REPORT 2014/15

Monash Children s Hospital Referral Guidelines PAEDIATRIC PLASTIC & RECONSTRUCTIVE SURGERY

Guidance for Clinicians Policies Document for INTERVENTIONS NOT NORMALLY FUNDED (INNF)

PLASTICS Referral Guidelines

North Derbyshire Clinical Commissioning Group EAST MIDLANDS COMMISSIONING POLICY FOR COSMETIC PROCEDURES (ALL AGES)

Plastic Surgery Referral Guidelines

Treatment or Removal of Benign Skin Lesions

Clinical Commissioning Group (CCG) Governing Body 2014/2015

REFERRAL GUIDELINES PLASTIC SURGERY

GROMMET INSERTION RECURRENT ACUTE OTITIS MEDIA (WITHOUT EFFUSION) SECONDARY CARE PRIOR APPROVAL POLICY

EAST MIDLANDS COMMISSIONING POLICY FOR COSMETIC PROCEDURES 2014 Version 2

EAST MIDLANDS COMMISSIONING POLICY FOR COSMETIC PROCEDURES 2014 Version 2.0

Thursday 21 st August Skin Problems

DERMATOLOGY ROTATION: COMPETENCY-BASED GOALS AND OBJECTIVES

NHS Greater Huddersfield, NHS North Kirklees & NHS Calderdale Clinical Commissioning Groups Commissioning Policy for Individual Funding Requests

DEPARTMENT OF DERMATOLOGY WALTER REED NATIONAL MILITARY MEDICAL CENTER BETHESDA MARYLAND

Placename CCG. Policies for the Commissioning of Healthcare. Policy for Managing Back Pain- Spinal Injections

Hauora Maori. Map. Non-Melanoma Skin Lesion. Clinically Seborrhoeic Keratosis. Management Options. Punch Biopsy. Refer to Public Skin Lesion Service

Data & Definitions Frequently Asked Questions

Data & Definitions Frequently Asked Questions

BREAST IMPLANT SURGERY INDIVIDUAL FUNDING REQUEST POLICY

July 2012 SKIN SURGERY SERVICE BRIEFING NOTES

Chapter 8 Skin Disorders and Diseases

Procedures of Limited Clinical Effectiveness (PoLCE)

Skin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry

Procedures of Lower Clinical Value Policy Walsall Clinical Commissioning Group November 2017

Hip Replacement Surgery Including referral for Surgical Assessment of Osteoarthritis Criteria Based Access Policy

Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley

Dr Stephen Hayes Associate Specialist in Dermatology University Hospital Southampton

Breast Surgery Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives

Undergraduate Dermatology Curriculum July 2016

Extract from EFFECTIVE CLINICAL COMMISSIONING POLICIES

Ellipse hair removal offers clinically-proven, safe and effective long-term removal of unwanted hair. How does Ellipse Hair Removal Work?

Specialised Services Policy: CP 44 Body Contouring

Skin cancer by the numbers

Greater Manchester EUR Policy Statement on: Common Benign Skin Lesions GM Ref: GM013 Version: 3.0 (15 Nov 2017)

Schedule of Benefits for General Practitioners

TONSILLECTOMY PRIOR APPROVAL POLICY

Specialised Services Commissioning Policy. CP29: Bariatric Surgery

A Cross-Sectional Survey of a Dermatology Outpatient Service in Malta

PHILLIPS CONSULTING GROUP, LLC

Varicose veins L85., L86., L87. Policy in place. Circumcision N30.3 Policy in place. Grommets D15.1 Policy in place

The Plastic Surgery See and Treat Skin Cancer Clinic (SATSKIN)

Service Specification: CPO Skin Lesions

LIPOSUCTION (COSMETIC) INDIVIDUAL FUNDING REQUEST POLICY

SERVICE RESTRICTION POLICY

Name of Policy: Pulsed Dye Laser Treatment of Recalcitrant Verrucae

4 ENT. 4.1 Bone anchored hearing aids. 4.2 Cochlear implants. (

Malignant Melanoma Care Pathway

Low back pain and sciatica in over 16s NICE quality standard

GROMMET INSERTION IN ADULTS WITH OTITIS MEDIA WITH EFFUSION (OME) SECONDARY CARE PRIOR APPROVAL POLICY

NHS Fylde and Wyre Clinical Commissioning Group. Policies for the Commissioning of Healthcare. Policy for surgical treatment of carpal tunnel syndrome

Policy for Procedures Not Funded

Skin cancer awareness for non-healthcare professionals

Policy for Procedures Not Routinely Funded

Dermatology GP Referral Guidelines

Commissioning Policy Individual Funding Request

Benefit Guidelines for Generating or Updating Referrals

Interesting Case Series. Rhinophyma

Accuracy of Clinical Skin Tumour Diagnosis in a Dermatological Setting.

HYPERHIDROSIS TREATMENT POLICY INDIVIDUAL FUNDING

ADENOIDECTOMY SECONDARY CARE PRIOR APPROVAL POLICY 1516.v1b

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)

Policy for Hysteroscopy Page 1 of 5. Policy for Hysteroscopy. V1.1 OPCS/ICD codes added. Version of: Version of: March 2018

PERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS) TREATMENT FOR URINARY INCONTINENCE SECONDARY CARE PRIOR APPROVAL POLICY

AILMENTS. when you can have R E A C H US FACIAL EXPRESSIONS. Dr. Nivedita Dadu's Dermatology Clinic

A Simple Guide to the Hyfrecator 2000

Position Statement Treatments that primarily affect the appearance are considered medically necessary only in the following circumstances:

Surgical Intervention for the Treatment of Hydrocele Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives

Diagnostics guidance Published: 11 November 2015 nice.org.uk/guidance/dg19

Value Based Clinical Commissioning Policies

DERMATOLOGY TRIAGE GUIDELINES

Governing Body (Public) Meeting

GREATER MANCHESTER RESPONSE TO NHS ENGLAND CONSULTATION ON EVIDENCE BASED INTERVENTIONS

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

BUNION (AND OTHER PAINFUL TOE CONDITION) SURGICAL TREATMENT POLICY PRIOR APPROVAL

Blackburn with Darwen Clinical Commissioning Group and East Lancashire Clinical Commissioning Group. Policies for the Commissioning of Healthcare

Clinical Policy: Benign Skin Lesion Removal Reference Number: CP.MP.HN150

Transcription:

Bradford and Airedale CCGs SKIN LESIONS Version: 2 Ratified by: Date ratified: Author(s): Responsible Committee: Consultant in Public Health Individual Funding Request Panel Date issue: September 2013 Reviewed: Intended audience: Version 1 Presented to Collab and Ratified : Sept 2012 Revised September 2013 IFR Panel, Provider Organisations, Referrers On behalf of Airedale, Wharfedale and Craven CCG, Bradford City CCG and Bradford Districts CCG 1

TREATMENT: Removal of Skin Lesions POLICY: Requests for Removal of Skin Lesions will be considered as a request for Plastic Surgery and subject to the screening and classification processes as detailed in the CCGs Commissioning Plastic Surgery: Guidance for Individual Funding Request Panel This commissioning policy will be used in conjunction with the above plastic surgery document to inform a decision on requests for removal of skin lesions. THIS POLICY DOES NOT APPLY TO ANY LESIONS WHERE CARCINOMA IS SUSPECTED - THESE SHOULD BE REFERRED UNDER THE APPROPRIATE PATHWAY PATHWAY/REFERRAL PROTOCOL:- Removal of skin lesions is funded on a Prior Approval basis according to the criteria detailed below: Commissioning Principles: The principles applying to this process are as set out in the document Commissioning Plastic Surgery: Guidance for Individual Funding Request Panel, and in particular the funding criteria, i.e.: Category 1 Reconstructive These requests will be funded routinely without need for Prior Approval or an Individual Funding Request Category 2 Functional These requests will be funded on Prior Approval if there is an existing commissioning pathway that the patient satisfies. If the patient does not satisfy an existing commissioning pathway, then the request will be funded on Prior Approval if: 1. Documentary evidence has been received that all other treatment options currently funded by the NHS have been exhausted or are contraindicated. 2. This is accompanied by a letter from a Consultant or appropriate specialist in the specialty related to the clinical reason cited for surgery (e.g. a Consultant Dermatologist or Consultant Psychiatrist) confirming that there are no suitable evidence-based treatment options other than surgery 2

If these conditions are not satisfied the request will be classed as an Individual Funding Request and will be processed as set out in the CCGs Policy and Procedures for Individual Funding Requests Category 3 Aesthetic These requests will be funded where the patient is defined as exceptional according to standard definition contained within the CCGs Policy and Procedures for Individual Funding Requests. Note - Assessment of patients being considered for referral to Plastic Surgery who may have an underlying genetic, endocrine or severe psychosocial condition should have had this fully investigated by a relevant specialist prior to the funding request being made. Patients will normally be expected to be 18 years old, or older. Category 4 Opportunistic These requests will be considered on a case by case basis and classified through the screening process as outlined above. Category 5 Other These requests will be considered on a case by case basis and classified through the screening process as outlined above. In addition: The CCGs consider that interventions to remove benign skin lesions satisfy the criterion of effectiveness on an operator dependent basis. The CCGs recognise that removal of benign skin lesions may result in scarring and will rely on the judgement of the clinician responsible for managing the patient s condition as to whether the benefits of the procedure are likely to outweigh the harm. The CCGs consider that interventions to remove benign skin lesions satisfy the criterion of cost effectiveness. The clinical opinion is that the benefit of the procedure in terms of symptom resolution for the individual patient outweighs the risk of harm (scarring). Scope This policy applies to surgical excision of skin lesions, including dermabrasion / shaving on any part of the body, including the face, unless they are covered separately by another discrete funding policy. Lesions This policy covers the following skin lesions, including facial lesions: Acne vulgaris and post acne scarring Benign pigmented melanocytic naevi (moles) Other pigmented lesions Comedones (blackheads); 3

Corns Dermal neurofibromas Dermatofibromas Ganglion (except wrist ganglion) Keloid scars Lipomata Milia Molluscum contagiosum lesions Rhinophyma Scars Sebaceous cysts (pilar and epidermoid cysts), Seborrhoeic keratoses Skin hypo-pigmentation Skin resurfacing techniques Skin tags Spider naevi Thread veins Other small benign, acquired vascular lesions including haemangioma, port wine stain, telangiectasia Veruccas Warts and plantar warts Xanthelasma (Note - The Individual Funding Requests Panel (IFRP) may apply this policy to unusual or rare lesions that are not listed above, should there be agreement by the Panel that the policy is appropriate) Exceptions The following are not appropriate for the IFR/Prior Approval process and should be referred through appropriate pathways Where there is a suspicion of malignancy the IFR or Prior Approval process is not appropriate, these cases should be urgently referred under the appropriate pathway with the exception of suspected basal cell carcinoma. (Note - If it is established that a skin lesion is not malignant, its removal will not normally be funded by the NHS though a clinician may request funding in exceptional cases). Diagnostic uncertainty where excision biopsy is necessary for diagnosis. As part of the treatment of specific conditions affecting the facial skin e.g. cutis laxa, pseudoxanthoma elasticum, neurofibromatosis. Facial palsy (congenital or acquired paralysis) 4

The correction of the consequences of trauma To correct deformity following surgery. Operations on congenital anomalies of the face and skull is usually available on the NHS. Some such conditions are considered highly specialised and are commissioned in the U.K. through the National Specialist Commissioning Advisory Group. Requests will be classified as Functional when: There is repeated trauma to the lesion due to its anatomical location, where all conservative measures have been exhausted as specified in the CCGs Commissioning Plastic Surgery: Guidance for Individual Funding Request Panel There is long-term risk of malignancy or disfigurement There is psychological distress where all conservative measures have been exhausted as specified in the CCGs Commissioning Plastic Surgery: Guidance for Individual Funding Request Panel There is persistent or recurrent infection where all conservative measures have been exhausted as specified in the CCGs Commissioning Plastic Surgery: Guidance for Individual Funding Request Panel There is drainage, inflammation, bleeding, burning, intense itching, or pain associated with the lesion where all conservative measures have been exhausted as specified in the CCGs Commissioning Plastic Surgery: Guidance for Individual Funding Request Panel The lesion obstructs a body orifice or vision leading to interference with normal function Notes on Specific Conditions All patients with congenital vascular lesions who have or potentially have functional problems should be referred for assessment Large benign tumours causing functional impairment and requiring general anaesthetic should be referred to secondary care Procedure for Applying for Prior Approval Requests for funding under Prior Approval should be submitted on a Form B, found on page 26 of the CCGs Policy and Procedures for Individual Funding Requests TREATMENT COSTS: Operative procedure PBR tariff 2013/2014 activity: 5